CHI Presents the 4th Annual Integrated R&D Informatics & Knowledge Management Conference

Nov. 9, 2011 - PRLog -- In the Pharmaceutical industry today, it is now critical to enable researchers to better predict outcomes and make good decisions. Developing integrated informatics systems and intelligent interfaces to support drug discovery and translational research continues to play a pivot role. CHI’s fourth annual Integrated R&D Informatics & Knowledge Management: Leveraging Data from Disparate Sources to Create Value conference will bring together thought leaders from across the life sciences to share their experiences dealing with moving large and complex data sets through public and private networks, the integration of disperse data streams  and the correlation between pre-clinical observations and clinical outcomes.

KEYNOTE SESSION (Part I):

New Frontiers for Research: Integrating the Virtual R&D Lab
Ingrid E. Akerblom, Ph.D., Executive Director, Discovery & Pre-Clinical IT, Merck Research Laboratories

Breaking through the Walls of Traditional Pharma to Access & Generate Information and Enable Innovation
Daniel H. Robertson, Ph.D., Senior Director, LRL IT Research, Eli Lilly & Co.

The Novartis Data Federation Initiative
Arturo J. Morales, Ph.D., Global Leader, Novartis Data Federation Initiative, Novartis Institutes for BioMedical Research, Inc.

KEYNOTE SESSION (Part II):

Surfing the Petabyte Waves - IT Partnering for Informatics and Computational Biology at the Broad Institute of MIT & Harvard
Martin Leach, Ph.D., CIO, Broad Institute

Disease and Translational Informatics: From Bioinformatics Playground to Critical Path
Juergen Hammer, Ph.D., M.B.A, Pharma Research & Early Development Informatics; Center Head, Global Head Disease and Translational Informatics, Roche Pharmaceuticals

New Approaches for Better Decisions
Anastasia M. Khoury Christianson, Ph.D., Senior Director, R&D Information, AstraZeneca Pharmaceuticals

As part of the Molecular Med TRI-CON 2012, attendees have access to 2 partnering forums, 5 symposia, 18 short courses, and 12 core programs. The event attracts more than 3,000 attendees and provides attendees an opportunity to interact with each other in the shared exhibit/poster hall, plenary keynotes and social functions.

Early registration discounts are available until November 18, 2011. To view the entire Informatics conference agenda and to register, please visit http://www.TriConference.com/IRD

To inquire about sponsoring and/or exhibiting, contact Jon Stroup, 781-972-5483, jstroup@healthtech.com.

Writers and editors are encouraged to attend. To request a press pass, contact Tracey Fielding at tfielding@healthtech.com.

About Cambridge Healthtech Institute (www.chicorporate.com)

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

Contact:
James Prudhomme
Cambridge Healthtech Institute
781-972-5400
jprudhomme@healthtech.com